Cargando…
Altered Expression of Shorter p53 Family Isoforms Can Impact Melanoma Aggressiveness
SIMPLE SUMMARY: TP53 is one of the most important tumor suppressor genes, which has been found to be mutated in more than half of human cancers and is considered the “Guardian of the genome”. However, it is rarely mutated in melanoma (less than 20% of cases). Although several cancer-oriented studies...
Autores principales: | Tadijan, Ana, Precazzini, Francesca, Hanžić, Nikolina, Radić, Martina, Gavioli, Nicolò, Vlašić, Ignacija, Ozretić, Petar, Pinto, Lia, Škreblin, Lidija, Barban, Giulia, Slade, Neda, Ciribilli, Yari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533715/ https://www.ncbi.nlm.nih.gov/pubmed/34680379 http://dx.doi.org/10.3390/cancers13205231 |
Ejemplares similares
-
p53/p73 Protein Network in Colorectal Cancer and Other Human Malignancies
por: Horvat, Anđela, et al.
Publicado: (2021) -
p53 Family in Resistance to Targeted Therapy of Melanoma
por: Vlašić, Ignacija, et al.
Publicado: (2022) -
Expression profiles of p53/p73, NME and GLI families in metastatic melanoma tissue and cell lines
por: Ozretić, Petar, et al.
Publicado: (2019) -
Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance
por: Radić, Martina, et al.
Publicado: (2022) -
Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions
por: Tadijan, Ana, et al.
Publicado: (2022)